Template:GHB background: Difference between revisions

(Created page with "==Background== *Abbreviation: GHB *Central nervous system depressant *Abused for: **Body building or sleep enhancement **euphoric, sexual, stimulant, and relaxant effects **...")
 
Line 8: Line 8:


===Pharmacokinetics===
===Pharmacokinetics===
*effect starts 15*20min, peaks in 30*60 min,  
*effect starts in 15-20min, peaks in 30-60 min,  
*lipid soluble, no protein binding so crosses BBB readily  
*lipid soluble, no protein binding so crosses BBB readily  
*elimination is dose dependant with half life of 20*50 min
*elimination is dose-dependent with half life of 20-50 min
*The duration of GHB's clinical effects depends upon the dose, and ranges from 2.5 to 4 hours
*The duration of GHB's clinical effects depends upon the dose, and ranges from 2.5 to 4 hours



Revision as of 05:21, 28 January 2021

Background

  • Abbreviation: GHB
  • Central nervous system depressant
  • Abused for:
    • Body building or sleep enhancement
    • euphoric, sexual, stimulant, and relaxant effects
    • Surreptitious drugging to facilitate sexual assault

Pharmacokinetics

  • effect starts in 15-20min, peaks in 30-60 min,
  • lipid soluble, no protein binding so crosses BBB readily
  • elimination is dose-dependent with half life of 20-50 min
  • The duration of GHB's clinical effects depends upon the dose, and ranges from 2.5 to 4 hours

Pharmacology

  • Is a metabolite and precursor of GABA
  • Interacts with GHB-specific receptors and also acts as a direct agonist of GABA-B receptors
  • Affects multiple neurotransmitter systems, including those of opioids, dopamine, serotonin, glutamate, and acetylcholine
  • Gamma butyrolactone (GBL) and 1,4 butanediol (BD) are GHB analogs that are rapidly metabolized to GHB after ingestion, with the same toxic and recreational effects